# Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)

Source: https://welltoldgrants.com/grants/for-fd-20-024-analgesic-anesthetic-and-addiction-clinical-trials/  
Official notice: https://www.grants.gov/search-results-detail/329610

> Food and Drug Administration offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It is no longer open on Grants.gov.

| Field | Value |
|---|---|
| Opportunity number | FOR-FD-20-024 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | not set |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses

## What the grant funds

ACTTION public-private partnership (PPP) is a multi-year, multi-phase initiative that is aligned with the FDA's Critical Path Initiative. This ppp has been designed to streamline the discovery and development process for new analgesic, anesthetic, addiction, and peripheral neuropathy medications. The ppp is expected to develop innovative approaches in clinical trial designs to support regulatory decision making. The key objectives of ACTTION involve initiating and supporting strategic collaborations among a broad spectrum of stakeholders — including academia, the FDA and other government agencies, industry, professional organizations, and patient advocacy groups — with the goals of sharing data and innovative thinking about the development of novel therapeutics. These strategic collaborations involve a wide range of research projects and other activities, such as scientific workshops, consensus meetings, and in-depth analyses of clinical trial data to determine the effects of research methods on study assay sensitivity and efficiency.

## Questions people ask

### Is FOR-FD-20-024 still open?

No. It is no longer open on Grants.gov. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)?

Food and Drug Administration accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

### What is the deadline for Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)?

Closed. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.